Patents-Review.com
🔗 Permalink
Assignee profile:

INTERVET INC.

City:

Madison, New Jersey

Country:

United States

Published Applications:

301

Last publication date:

2025-11-13

Patent Grants:

208

Last grant date:

2025-08-12

Quarterly INTERVET INC. Patent Applications

Top Inventors for applications by INTERVET INC.

These are the the leading inventors for applications assigned to INTERVET INC.:

Recent patent applications by INTERVET INC.

INTERVET INC. based in Madison, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-11-13
US20250346657A1
Chemistry; metallurgy

CANINIZED AND FELINIZED ANTIBODIES TO HUMAN NGF

 #2 | 2025-11-06
US20250340654A1
Chemistry; metallurgy

CANINIZED ANTIBODIES TO CANINE INTERLEUKIN-31 RECEPTOR ALPHA II

 #3 | 2025-11-06
US20250340653A1
Chemistry; metallurgy

CANINIZED ANTIBODIES TO CANINE INTERLEUKIN-31 RECEPTOR ALPHA I

 #4 | 2025-11-06
US20250340626A1
Chemistry; metallurgy

CANINIZED ANTIBODIES TO HUMAN NGF

 #5 | 2025-05-01
US20250134979A1
Human necessities

DNA VACCINE AGAINST LEISHMANIASIS

 #6 | 2025-02-20
US20250057938A1
Human necessities

STABILISED LIQUID VACCINES OF LIVE VIRUSES

 #7 | 2025-02-20
US20250057934A1
Human necessities

STABLE EMULSIONS OF ANTIGENS

 #8 | 2025-01-09
US20250011730A1
Chemistry; metallurgy

NOVEL PORCINE ROTAVIRUS

 #9 | 2024-06-20 ✅ Patent 12,383,610 granted on 2025-08-12
US20240197851A1
Human necessities

A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS SEROTYPE 9, SEQUENCE TYPE 16

 #10 | 2024-04-18 ✅ Patent 12,514,922 granted on 2026-01-06
US20240123057A1
Human necessities

Recombinant Non-Pathogenic Marek's Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus and Infectious Bursal Disease Virus Antigens

 #11 | 2024-04-11
US20240115685A1
Human necessities

CONJUGATED FUMONISIN TO PROTECT AGAINST MYCOTOXICOSIS

 #12 | 2024-03-14
US20240084004A1
Chemistry; metallurgy

ANTIBODIES AGAINST CANINE PD-1

 #13 | 2024-02-22
US20240058436A1
Human necessities

MULTIVALENT HVT VECTOR VACCINE

 #14 | 2024-02-22 ✅ Patent 12,605,396 granted on 2026-04-21
US20240058366A1
Human necessities

METHODS OF TREATING MASTITIS WITH AN ORTHOSOMYCIN ANTIMICROBIAL COMPOUND

 #15 | 2024-02-15
US20240053340A1
Physics

AFRICAN SWINE FEVER DIVA IMMUNOASSAY

 #16 | 2024-02-15
US20240051943A1
Chemistry; metallurgy

A PROCESS FOR THE PREPARATION OF N-(BIS(4-METHOXYPHENYL)METHYL)-6-OXO-2-(PYRIDAZIN-3-YL)-1,6-DIHYDROPYRIMIDINE-5-CARBOXAMIDE

 #17 | 2024-02-08
US20240043446A1
Chemistry; metallurgy

ANTHELMINTIC COMPOUNDS COMPRISING A THIENOPYRIDINE STRUCTURE

 #18 | 2024-02-08
US20240043385A1
Chemistry; metallurgy

ANTHELMINTIC COMPOUNDS COMPRISING A PYRIDINE STRUCTURE

 #19 | 2024-01-25
US20240024496A1
Human necessities

CONJUGATED ZEARALENONE TO PROTECT AGAINST MYCOTOXICOSIS

 #20 | 2024-01-25
US20240024456A1
Human necessities

HA STEM VACCINE FOR HA ANTIBODY-POSITIVE TARGETS

 #21 | 2024-01-25
US20240024446A1
Human necessities

CONJUGATED AFLATOXIN B TO PROTECT AGAINST MYCOTOXICOSIS

 #22 | 2024-01-25
US20240024395A1
Human necessities

CONJUGATED T-2 TOXIN TO PROTECT AGAINST MYCOTOXICOSIS

 #23 | 2024-01-11
US20240009303A1
Human necessities

COMBINATION VACCINE FOR PROTECTING SWINE AGAINST VARIOUS DISORDERS

 #24 | 2024-01-04
US20240002518A1
Chemistry; metallurgy

CANINIZED RAT ANTIBODIES TO CANINE INTERLEUKIN-31 RECEPTOR ALPHA

 #25 | 2024-01-04
US20240000920A1
Human necessities

RECOMBINANT VECTORS ENCODING CHIMERIC CORONAVIRUS SPIKE PROTEINS AND USE THEREOF

 #26 | 2024-01-04
US20240000820A1
Human necessities

A METHOD OF TREATING FOOT ROT

 #27 | 2023-12-21
US20230405110A1
Human necessities

Canine Parvovirus

 #28 | 2023-12-14
US20230399363A1
Chemistry; metallurgy

BACULOVIRUS EXPRESSION VECTOR

 #29 | 2023-12-07
US20230390380A1
Human necessities

BACULOVIRUS EXPRESSION VECTOR

 #30 | 2023-12-07
US20230390260A1
Human necessities

METHOD OF TREATMENT OF PAIN THROUGH BUCCAL ADMINISTRATION OF FLUNIXIN

 #31 | 2023-11-16
US20230363359A1
Human necessities

METHOD FOR AUTOMATIC SEA LICE MONITORING IN SALMON AQUACULTURE

 #32 | 2023-11-09
US20230355741A1
Human necessities

Feline Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine

 #33 | 2023-10-26
US20230340032A1
Chemistry; metallurgy

NOVEL ERYTHROPARVOVIRUS ASSOCIATED WITH RESPIRATORY DISTRESS IN EQUINE

 #34 | 2023-10-26 ✅ Patent 12,594,328 granted on 2026-04-07
US20230338500A1
Human necessities

A COMBINATION OF VACCINES TO PROPHYLACTICALLY TREAT A PIG

 #35 | 2023-10-12
US20230320981A1
Human necessities

SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS

 #36 | 2023-10-05
US20230310386A1
Human necessities

INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

 #37 | 2023-09-21
US20230295289A1
Chemistry; metallurgy

Bispecific Caninized Antibodies and Bispecific Binding Partners for Treating Atopic Dermatitis

 #38 | 2023-09-07 ✅ Patent 12,636,359 granted on 2026-05-26
US20230277649A1
Human necessities

SWINE INFLUENZA A VIRUS VACCINE COMPRISING TWO DISTINCT RNA REPLICON PARTICLES

 #39 | 2023-08-10 ✅ Patent 12,630,640 granted on 2026-05-19
US20230250177A1
Chemistry; metallurgy

Bispecific Caninized Antibodies for Treating Atopic Dermatitis

 #40 | 2023-08-10
US20230248817A1
Human necessities

SWINE INFLUENZA A VIRUS VACCINE COMPRISING A NUCLEIC ACID CONSTRUCT COMPRISING FIRST, SECOND AND THIRD NUCLEIC ACID SEQUENCES ENCODING DISTINCT NEURAMINIDASE ANTIGENS OF THE VIRUS

 #41 | 2023-07-27
US20230233530A1
Human necessities

IMPLANTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

 #42 | 2023-06-22 ✅ Patent 11,849,707 granted on 2023-12-26
US20230189767A1
Human necessities

Method and system for external fish parasite monitoring in aquaculture

 #43 | 2023-06-08
US20230174996A1
Chemistry; metallurgy

REASSORTED ISA VIRUS

 #44 | 2023-06-01 ✅ Patent 12,193,837 granted on 2025-01-14
US20230165525A1
Human necessities

System and method for assessing animals considering auscultation and evaluation of physiological responses in various environments

 #45 | 2023-05-25 ✅ Patent 12,201,815 granted on 2025-01-21
US20230158240A1
Human necessities

Device for administering a fluid

 #46 | 2023-05-11 ✅ Patent 12,509,449 granted on 2025-12-30
US20230148316A1
Chemistry; metallurgy

ANTHELMINTIC COMPOUNDS COMPRISING A QUINOLINE STRUCTURE

 #47 | 2023-05-11 ✅ Patent 12,564,629 granted on 2026-03-03
US20230145957A1
Human necessities

A VACCINE TO PROTECT AGAINST MYCOPLASMA HYOPNEUMONIAE

 #48 | 2023-04-13 ✅ Patent 12,479,841 granted on 2025-11-25
US20230110397A1
Chemistry; metallurgy

ANTHELMINTIC COMPOUNDS COMPRISING AZAINDOLES STRUCTURE

 #49 | 2023-04-06 ✅ Patent 12,502,426 granted on 2025-12-23
US20230105140A1
Human necessities

INACTIVATED PISCINE ORTHOREOVIRUS VACCINE

 #50 | 2023-03-30
US20230095926A1
Human necessities

PARASITE CONTROL IN RUMINANTS

 #51 | 2023-03-09 ✅ Patent 12,564,581 granted on 2026-03-03
US20230070369A1
Human necessities

PYRAZOLE PHARMACEUTICAL COMPOSITION

 #52 | 2023-03-02
US20230062746A1
Human necessities

A PHARMACEUTICAL COMPOSITION OF A PYRAZOLE COMPOUND DISPERSED IN A POLYMER MATRIX

 #53 | 2023-02-16
US20230053131A1
Chemistry; metallurgy

ANTIBODIES TO CANINE INTERLEUKIN-4 RECEPTOR ALPHA

 #54 | 2023-02-09 ✅ Patent 12,545,738 granted on 2026-02-10
US20230044037A1
Chemistry; metallurgy

CANINE INTERLEUKIN-4 RECEPTOR ALPHA ANTIBODIES

 #55 | 2023-02-02 ✅ Patent 12,589,147 granted on 2026-03-31
US20230031097A1
Human necessities

MULTIVALENT HVT VECTOR VACCINE

 #56 | 2023-01-19 ✅ Patent 12,448,417 granted on 2025-10-21
US20230015910A1
Chemistry; metallurgy

CRYPTOSPORIDIOSIS VACCINE

 #57 | 2023-01-12
US20230012140A1
Human necessities

ORAL RESPIRATORY VACCINE

 #58 | 2023-01-05
US20230000813A1
Human necessities

COMPOUND FOR THE TREATMENT OF BOVINE OR SWINE RESPIRATORY DISEASE

 #59 | 2022-12-08
US20220389114A1
Chemistry; metallurgy

PD-L1 ANTIBODIES BINDING CANINE PD-L1

 #60 | 2022-12-08
US20220387577A1
Human necessities

A NOVEL VACCINE AGAINST HEAMOPHILUS PARASUIS

 #61 | 2022-12-01
US20220378900A1
Human necessities

A NOVEL VACCINE AGAINST HEAMOPHILUS PARASUIS

 #62 | 2022-12-01
US20220378899A1
Human necessities

A NOVEL VACCINE AGAINST HEAMOPHILUS PARASUIS

 #63 | 2022-11-03 ✅ Patent 11,741,731 granted on 2023-08-29
US20220351531A1
Physics

Automated parasite analysis system

 #64 | 2022-10-27
US20220339276A1
Human necessities

A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS

 #65 | 2022-10-13
US20220323421A1
Human necessities

Soft Chewable Veterinary Dosage Form

 #66 | 2022-10-06
US20220315953A1
Chemistry; metallurgy

MDBK IRF3/IRF7 KNOCK OUT MUTANT CELL AND ITS USE FOR VACCINE PRODUCTION

 #67 | 2022-09-22 ✅ Patent 12,616,677 granted on 2026-05-05
US20220296564A1
Human necessities

INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

 #68 | 2022-08-11 ✅ Patent 12,552,864 granted on 2026-02-17
US20220251209A1
Chemistry; metallurgy

CANINIZED ANTIBODIES TO HUMAN CTLA-4

 #69 | 2022-08-11 ✅ Patent 12,435,143 granted on 2025-10-07
US20220251208A1
Chemistry; metallurgy

Caninized Antibodies Against Canine CTLA-4

 #70 | 2022-07-28 ✅ Patent 12,383,612 granted on 2025-08-12
US20220233675A1
Human necessities

VACCINE TO PROTECT A PIG AGAINST ACTINOBACILLUS PLEUROPNEUMONIAE

 #71 | 2022-07-28 ✅ Patent 12,280,035 granted on 2025-04-22
US20220233496A1
Human necessities

Conjugated deoxynivalenol to protect against mycotoxicosis

 #72 | 2022-07-21
US20220227769A1
Chemistry; metallurgy

CRYSTALLINE FORM OF TELMAPITANT OR (5R,8S)-8-[[(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY]METHYL]-8-PHENYL-1,3,7-TRIAZASPIRO[4.5]DECANE-2,4-DIONE

 #73 | 2022-07-14 ✅ Patent 12,297,459 granted on 2025-05-13
US20220220452A1
Chemistry; metallurgy

Porcine rotavirus

 #74 | 2022-07-07 ✅ Patent 12,076,392 granted on 2024-09-03
US20220211839A1
Human necessities

Feline leukemia virus vaccine

 #75 | 2022-06-30 ✅ Patent 12,252,536 granted on 2025-03-18
US20220204615A1
Chemistry; metallurgy

Caninized antibodies

 #76 | 2022-06-30 ✅ Patent 12,281,104 granted on 2025-04-22
US20220204483A1
Chemistry; metallurgy

Process for the production of ethyl 3-amino-1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]pyrazole-4-carboxylate through chiral separation of a racemic mixture

 #77 | 2022-06-23 ✅ Patent 12,128,032 granted on 2024-10-29
US20220193040A1
Human necessities

Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultry

 #78 | 2022-06-09 ✅ Patent 12,214,027 granted on 2025-02-04
US20220175902A1
Human necessities

Stabilisation of live mollicutes bacteria in a liquid composition

 #79 | 2022-05-12 ✅ Patent 12,396,945 granted on 2025-08-26
US20220142984A1
Human necessities

Soft Chewable Pharmaceutical Products

 #80 | 2022-04-28 ✅ Patent 11,596,687 granted on 2023-03-07
US20220125915A1
Human necessities

Recombinant non-pathogenic Marek's disease virus constructs encoding infectious laryngotracheitis virus and infectious bursal disease virus antigens

 #81 | 2022-03-24 ✅ Patent 12,239,704 granted on 2025-03-04
US20220088187A1
Human necessities

Recombinant non-pathogenic Marek's disease virus constructs encoding multiple heterologous antigens

 #82 | 2022-03-17 ✅ Patent 12,564,626 granted on 2026-03-03
US20220080040A1
Human necessities

SERUM FREE INTRACELLULAR PATHOGEN VACCINE

 #83 | 2022-03-10 ✅ Patent 11,548,859 granted on 2023-01-10
US20220073479A1
Chemistry; metallurgy

Method for producing (5,S)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4Hisoxazol-3-yl]-2-methyl-benzoic acid

 #84 | 2022-02-24 ✅ Patent 12,221,486 granted on 2025-02-11
US20220056143A1
Chemistry; metallurgy

Caninized human antibodies to human IL-4R alpha

 #85 | 2022-02-17 ✅ Patent 11,530,187 granted on 2022-12-20
US20220048874A1
Chemistry; metallurgy

Method for producing (5S)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-benzoic acid

 #86 | 2022-02-10 ✅ Patent 12,077,514 granted on 2024-09-03
US20220041564A1
Chemistry; metallurgy

Method for racemisation of (5R)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H¬isoxazol-3-yl]-2-methyl-benzoic acid

 #87 | 2022-02-10 ✅ Patent 12,077,488 granted on 2024-09-03
US20220041547A1
Chemistry; metallurgy

Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection

 #88 | 2022-01-27 ✅ Patent 12,018,020 granted on 2024-06-25
US20220024902A1
Chemistry; metallurgy

Crystalline forms of 1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]pyrazole-4-carboxamide

 #89 | 2022-01-27 ✅ Patent 12,161,713 granted on 2024-12-10
US20220023414A1
Human necessities

Prime-boost vaccination regimen

 #90 | 2022-01-20 ✅ Patent 12,479,835 granted on 2025-11-25
US20220017499A1
Chemistry; metallurgy

Process for Preparing 1-([3R,4S)-4-Cyanotetrahydropyran-3-YL]-3-[(2-fluoro-6-Methoxy-4-Pyridyl)Amino]Pyrazole-4-Carboxamide

 #91 | 2022-01-13 ✅ Patent 11,730,809 granted on 2023-08-22
US20220008532A1
Human necessities

Multivalent feline vaccine

 #92 | 2022-01-06 ✅ Patent 12,023,374 granted on 2024-07-02
US20220001003A1
Human necessities

Vaccine for protection against

#93 | 2021-12-09 ✅ Patent 12,246,090 granted on 2025-03-11
US20210378957A1
Human necessities

Stable emulsions of bacterial antigens

 #94 | 2021-12-02 ✅ Patent 11,696,944 granted on 2023-07-11
US20210369832A1
Human necessities

Vaccine for protection against

#95 | 2021-11-25
US20210361565A1
Human necessities

Oral Pharmaceutical Composition of an NK-1 Antagonist

 #96 | 2021-11-18 ✅ Patent 11,878,006 granted on 2024-01-23
US20210354283A1
Performing operations; transporting

Isoxazoline solution containing vitamin E for use with sanitized drinking water

 #97 | 2021-11-18 ✅ Patent 11,883,530 granted on 2024-01-30
US20210353537A1
Human necessities

Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals

 #98 | 2021-11-11 ✅ Patent 12,157,717 granted on 2024-12-03
US20210347730A1
Chemistry; metallurgy

Compounds for the treatment of bovine or swine respiratory disease

 #99 | 2021-10-14
US20210317077A1
Chemistry; metallurgy

Crystalline Forms of N1-(1-Cyanocycloproply)-N2-((1S)-1-{4'-[(1R-2,2-Difluoro-1-Hydroxyethyl]Biphenyl-4-YL}-2,2,2-Trifluoroethyl)-4-Fluoro-L-Leucinamide

 #100 | 2021-09-30
US20210300863A1
Chemistry; metallurgy

PROCESS TO MAKE A SELECTIVE CATHEPSIN CYSTEINE PROTEASE INHIBITOR

Also check out Intervet Inc.'s (Madison, United States) applicant profile with 182 patent applications submitted.

AssigneeID:

103644 ⎘